Patient Experiences with Psoriatic Disease in the USA: Results from the Psoriasis and Beyond Global Study
This analysis of USA-based patients with PsD highlights the profound impact of PsD on emotional well-being and QoL and suggests potential underdiagnosis of PsA. There is a need to ensure early PsD diagnosis and to provide holistic treatment, including mental health support.
Authors
- Alexis Ogdie (ORCID: https://orcid.org/0000-0002-4639-0775)
- Sicily Mburu (ORCID: https://orcid.org/0000-0003-1296-4520)
- April Wang Armstrong (ORCID: https://orcid.org/0000-0003-0064-8707)
- Elena Kornyeyeva
- George Gondo (ORCID: https://orcid.org/0000-0002-6468-0397)
- Susan Frade
Institutions
- Novartis (Switzerland) (CH)
- University of California, Los Angeles (US)
- ASIS Foundation (US)
- University of Pennsylvania (US)
Publication Details
- Journal
- Drugs - Real World Outcomes
- Published
- 2025-08-29
- DOI
- https://doi.org/10.1007/s40801-025-00499-6
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Psoriasis Foundation
- Novartis
- Novartis Pharmaceuticals Corporation